The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukemia adults in complete remission: A systematic review and meta-analysis.
 
Muhammad Umair Mushtaq
Research Funding - Iovance Biotherapeutics (Inst)
 
Pramod Singh
No Relationships to Disclose
 
Asad Zaman
No Relationships to Disclose
 
Muhammad Abdullah Humayun
No Relationships to Disclose
 
Abdul Rafae Faisal
No Relationships to Disclose
 
Ali Shan Hafeez
No Relationships to Disclose
 
Hameer Ali
No Relationships to Disclose
 
Muhammad Faizan
No Relationships to Disclose
 
Waseh Ahsan
No Relationships to Disclose
 
Arfa Ahmed
No Relationships to Disclose
 
Rameesha Mehreen
No Relationships to Disclose
 
Muhammad Ahmad Sadiq
No Relationships to Disclose
 
Saba Sattar
No Relationships to Disclose
 
Muhammad Kashif Amin
No Relationships to Disclose
 
Joseph McGuirk
Employment - University of Kansas Health System
Leadership - University of Kansas Cancer Center
Honoraria - AlloVir; Autolus; Bristol-Myers Squibb/Sanofi; CARGO Therapeutics; crispr therapeutics; Kite, a Gilead company; Legend Biotech; Nektar; Novartis; Sana Biotechnology
Consulting or Advisory Role - Allovir; crispr therapeutics; EcoR1 Capital; Fosun Kite Biotechnology Co., Ltd.; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics; Nektar; Novartis; Sana Biotechnology, Inc.; Sanofi US Services, Inc.
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; SITC/ACCC; Syncopation Life Sciences
 
Moazzam Shahzad
No Relationships to Disclose